HQ
HealthEquity
HQY · NASDAQ
$88.25 -0.84% (-$0.75)
1M -5.50%
Market Cap $7.41B
P/E Ratio 31.32x
Div. Yield -
ROE 11.43%
Bulios Fair Price
$48.42
45.1% downside
Current Price
$88.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HQY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
57 /100
Fair P/E 31.32x
P/FCF 15.70x
EV/EBITDA 15.32x
Growth
86 /100
Growing Rev. growth 15.08%
Book val. growth 3.59%
FCF growth 143.50%
Profitability
99 /100
Strong Gross margin 75.21%
FCF margin 34.63%
Net margin 17.36%
Quality
51 /100
Average ROIC 8.99%
Asset turnover 0.42x
ROE 11.43%
Debt
93 /100
Low Debt/Equity 0.02x
Net debt/EBITDA -0.46x
Current ratio 2.99x
Stability
39 /100
Moderate Beta 0.23x
Profitable years 3
Rev. volatility 5.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HQY
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Scott R. Cutler
Employees
2,814
Headquarters
Draper
Upcoming events
02 DEC
Earnings
Upcoming earnings report